<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effect of cavinton on the systemic (by the method of diluting Evans blue according to Stewart-Hamilton) and cerebral (by the method of rheoencephalography) hemodynamics was examined in 38 patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> insufficiency of the cerebral circulation (CICC) in the presence of either <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> alone (n = 22) and its combination with arterial <z:hpo ids='HP_0000822'>hypertension</z:hpo> (n = 16) </plain></SENT>
<SENT sid="1" pm="."><plain>Cavinton decreased the peripheral vascular resistance and the tone of the small and median vessels of the brain, increased the cardiac output and improved the rheological properties of the blood (it lowered the globular volume, viscosity and hematocrit) </plain></SENT>
<SENT sid="2" pm="."><plain>The best results were attained with the parenteral administration of the drug </plain></SENT>
<SENT sid="3" pm="."><plain>Indications for and contraindications to cavinton in patients with CICC are discussed </plain></SENT>
</text></document>